Quantitative research platform for building and testing systematic trading strategies with point-in-time backtests and walk-forward validation
US company financials, year by year
Stage
Startup
Not given
Founded
2025
Not given
Based in
DE
GB
Pricing model
Freemium
Freemium
Pricing
Starter €7.99/month, Practitioner €19.50/month (regularly €39), Research €34.50/month (regularly €69). All prices include VAT. Every new account gets 30 days of Practitioner free with no card required.
Free: latest 5 years of financials and prices, key ratios, recent insider trades, first line of risk-factor changes, watchlist up to 5 companies, 1 full-history export per month. Pro: $69/year or $8.99/month. Unlimited: $149/year or $17.99/month. Lifetime: $199 once. 30-day money-back guarantee appl
Key features
Visual strategy builder with circuit diagram interface
Point-in-time backtesting over 20 years of history
Walk-forward validation and robustness testing
Indicator strategies with mean reversion and momentum
Stochastic methods including Kalman filter and Ornstein-Uhlenbeck models
Factor model and portfolio construction tools
Paper trading with daily marked prices
Python code export for backtests and strategies
Regime analysis and market regime detection
Annual financial statements and ratios from FY2007
Share price data since 2000
Export data to Excel or CSV
Covers 505 US public companies
Quarterly financial data on Pro plan
Hourly email alerts for new reports and trades
Linked access to 10-K reports at sec.gov
What makes it different
Point-in-time data discipline prevents look-ahead bias and ensures strategies see only information available on each date
113 published research articles and studies with reproducible methodology and full audit trail
Circuit diagram interface makes strategy design accessible without requiring extensive coding
Full Python export enables strategies to be deployed outside the platform
Figures verified against official SEC 10-K filings
Full history from FY2007 in one table with one-click export
Covers data most sites do not show: risk-factor changes, quarterly data
QuanterLab
StockYears